The document discusses looking at data from an aspirin regimen group and a placebo group in a different way by comparing the percentages that had a heart attack in each group. Considering the percentages that had a heart attack in the aspirin group versus the placebo group may provide a different impression of the impact of aspirin on heart attacks compared to just looking at the raw data.